Allarity Therapeutics, Inc. (ALLR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.53M |
| Enterprise Value | 2.24M |
| P/E Ratio | -1.33 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 47.96 |
| Price/Book Ratio | 4.68 |
| Enterprise/Revenue | 63.34 |
| Enterprise/EBITDA | -1.97 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -35.75 |
| Operating Margin | -31.29 |
AD
Management Effectiveness
| Return On Assets | -0.38 |
| Return On Equity | -1.53 |
Income Statement
| Revenue | 320,000 |
| Revenue/Share | 0.02 |
| Gross Profit | 320,000 |
| EBITDA | -11.05M |
| Net Income | -11.23M |
| Diluted EPS | -0.78 |
Balance Sheet
| Total Cash | 16.98M |
| Total Cash/Share | 1.07 |
| Total Debt | 22.29M |
| Total Debt/Equity | 6.3 |
| Current Ratio | 1.11 |
| Book Value Per Share | 0.22 |
Price History
| 52-Week Change | -35.8 |
| 52-Week High | 1.84 |
| 52-Week Low | 0.77 |
| Moving Average 50 Days | 1.26 |
| Moving Average 200 Days | 1.24 |
Statistics
| Average Volume | 100,804 |
| Shares Outstanding | 15.91M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | September 11, 2024 |
AD
